Versant Venture Management, LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 66 filers reported holding IMMUNE DESIGN CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Versant Venture Management, LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2018$2,870,673,000
-62.3%
2,208,2100.0%1.42%
-45.2%
Q3 2018$7,618,325,000
-24.2%
2,208,2100.0%2.59%
-17.4%
Q2 2018$10,047,356,000
+37.9%
2,208,2100.0%3.14%
+34.5%
Q1 2018$7,287,093,000
-15.4%
2,208,2100.0%2.33%
-74.3%
Q4 2017$8,612,019,000
-62.9%
2,208,2100.0%9.06%
-48.8%
Q3 2017$23,239,423,000
+9.1%
2,208,2100.0%17.69%
+5.5%
Q2 2017$21,309,227,000
+41.9%
2,208,2100.0%16.76%
+53.5%
Q1 2017$15,015,828,000
+23.6%
2,208,2100.0%10.92%
-7.6%
Q4 2016$12,145,155,000
-27.4%
2,208,2100.0%11.82%
-36.7%
Q3 2016$16,738,232,0002,208,21018.66%
Other shareholders
IMMUNE DESIGN CORP shareholders Q3 2017
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,962,720$39,411,0007.61%
NEXTHERA CAPITAL LP 40,000$803,0001.14%
SECTORAL ASSET MANAGEMENT INC 856,867$17,206,0000.73%
Cormorant Asset Management, LP 189,000$3,795,0000.45%
SPHERA FUNDS MANAGEMENT LTD. 153,000$3,072,0000.45%
RS INVESTMENT MANAGEMENT CO LLC 1,108,576$22,260,0000.20%
Eventide Asset Management 180,000$3,614,0000.18%
Focused Wealth Management, Inc 12,898$259,0000.15%
Vident Investment Advisory, LLC 38,384$771,0000.10%
OXFORD ASSET MANAGEMENT LLP 56,248$1,166,0000.03%
View complete list of IMMUNE DESIGN CORP shareholders